A 2-yr national population study of pediatric ketoacidosis in Sweden: Predisposing conditions and insulin pump use

Pediatric Diabetes

Volumn 10, Issue 1, 2009, Pages 33-37

  Hanas, Ragnar ^a   Lindgren, Fredrik ^b   Lindblad, Bengt ^c  

^a UDDEVALLA HOSPITAL   (Sweden)

^b SACHS CHILDREN S HOSPITAL   (Sweden)

^c QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

Author keywords

CSII; Diabetes; DKA; Gastroenteritis; Insulin pump; Ketoacidosis

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ALCOHOL CONSUMPTION; ARTICLE; BLOOD PH; CHILD; CONTINUOUS INFUSION; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; DISEASE DURATION; DISEASE PREDISPOSITION; DRUG USE; FEMALE; GASTROENTERITIS; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; INCIDENCE; INFECTION; INFUSION PUMP; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PATIENT ATTITUDE; PATIENT COMPLIANCE; POPULATION RESEARCH; PRIORITY JOURNAL; RISK FACTOR; SWEDEN;

ADOLESCENT; AGE OF ONSET; CHILD; CHILD, PRESCHOOL; DIABETIC KETOACIDOSIS; HUMANS; INSULIN INFUSION SYSTEMS; POTASSIUM; QUESTIONNAIRES; SODIUM; SWEDEN;

EID: 59149101096     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2008.00441.x     Document Type: Article

References (41)

1. Diabetes Control and Complications Trial Research Group. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. J Pediatr 1994: 125: 177-188.
2. Implementation of treatment protocols in the Diabetes Control and Complications Trial. Diabetes Care 1995: 18: 361-376.
3. Egger M, Davey Smith G, Stettler C, Diem P. Risk of adverse effects of intensified treatment in insulin-dependent diabetes mellitus: A meta-analysis. Diabet Med 1997: 14: 919-928.
4. Smith CP, Firth D, Bennett S, Howard C, Chisholm P. Ketoacidosis occurring in newly diagnosed and established diabetic children. Acta Paediatr 1998: 87: 537-541.
5. Flood RG, Chiang VW. Rate and prediction of infection in children with diabetic ketoacidosis. Am J Emerg Med 2001: 19: 270-273.
6. Smaldone A, Honig J, Stone PW, Arons R, Weinger K. Characteristics of California children with single versus multiple diabetic ketoacidosis hospitalizations (1998-2000). Diabetes Care 2005: 28: 2082-2084.
7. Plotnick LP, Clark LM, Brancati FL, Erlinger T. Safety and effectiveness of insulin pump therapy in children and adolescents with type 1 diabetes. Diabetes Care 2003: 26: 1142-1146.
8. Sulli N, Shashaj B. Long-term benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes: A 4-year follow-up. Diabet Med 2006: 23: 900-906.
9. Weinzimer SA, Ahern JH, Doyle EA, Vincent MR, Dziura J, Steffen AT. Persistence of benefits of continuous subcutaneous insulin infusion in very young children with type 1 diabetes: A follow-up report. Pediatrics 2004: 114: 1601-1605.
10. Hanas R, Adolfsson P. Insulin pumps in pediatric routine care improve long-term metabolic control without increasing the risk of hypoglycemia. Pediatr Diabetes 2006: 7: 25-31.
11. Maniatis AK, Klingensmith GJ, Slover RH, Mowry CJ, Chase HP. Continuous subcutaneous insulin infusion therapy for children and adolescents: An option for routine diabetes care. Pediatrics 2001: 107: 351-356.
12. Liberatore R Jr, Perlman K, Buccino J, Artiles-Sisk A, Daneman D. Continuous subcutaneous insulin infusion pump treatment in children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2004: 17: 223-226.
13. Danne T, Battelino T, Jarosz-Chobot P et al. The PedPump Study: A low percentage of basal insulin and more than five daily boluses are associated with better centralized HbA1c in 1041 children on CSII from 17 countries. Diabetes 2005: 54 (Suppl. 1): A453 (abstract).
14. Mecklenburg RS, Benson EA, Benson JW Jr, Fredlund PN, Guinn T, Metz RJ. Acute complications associated with insulin infusion pump therapy. Report of experience with 161 patients. JAMA 1984: 252: 3265-3269.
15. Hanas R, Ludvigsson J. Hypoglycemia and ketoacidosis with insulin pump therapy in children and adolescents. Pediatr Diabetes 2006: 7 (Suppl. 4): 32-38.
16. Hanas R. Selection for and initiation of continuous subcutaneous insulin infusion. Proceedings from a workshop. Horm Res 2002: 57 (Suppl. 1): 101-104.
17. Weintrob N, Benzaquen H, Galatzer A, Shalitin S, Lazar L, Fayman G. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: A randomized open crossover trial. Pediatrics 2003: 112: 559-564.
18. Di Meglio LA, Pottorff TM, Boyd SR, France L, Fineberg N, Eugster EA. A randomized, controlled study of insulin pump therapy in diabetic preschoolers. J Pediatr 2004: 145: 380-384.
19. Wilson DM, Buckingham BA, Kunselman EL, Sullivan MM, Paguntalan HU, Gitelman SE. A two-center randomized controlled feasibility trial of insulin pump therapy in young children with diabetes. Diabetes Care 2005: 28: 15-19.
20. Hanas R, Lindgren F, Lindblad B. Diabetic ketoacidosis and cerebral oedema in Sweden - a 2-year paediatric population study. Diabet Med 2007: 24: 1080-1085.
21. Arnqvist H, Wallensteen M, Jeppson JO. [Standards for long-term measures of blood sugar are established]. Lakartidningen 1997: 94: 4789-4790.
22. Hoelzel W, Weykamp C, Jeppsson JO, Miedema K, Barr JR, Goodall I. IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: A method-comparison study. Clin Chem 2004: 50: 166-174.
23. Preacher K. Calculation for the chi-square test: An interactive calculation tool for chi-square tests of goodness of fit and independence [computer software] 2001 (available from http://wwwquantpsyorg).
24. Hanberger L, Samuelsson U, Lindblad B, Ludvigsson J. A1C in children and adolescents with diabetes in relation to certain clinical parameters: the Swedish Childhood Diabetes Registry SWEDIABKIDS. Diabetes Care 2008: 31: 927-929.
25. Kitabchi AE, Wall BM. Diabetic ketoacidosis. Med Clin North Am 1995: 79: 9-37.
26. Morris AD, Boyle DI, McMahon AD, Greene SA, MacDonald TM, Newton RW. Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitus. Lancet 1997: 350: 1505-1510.
27. Malone JI, Root AW. Plasma free insulin concentrations: Keystone to effective management of diabetes mellitus in children. J Pediatr 1981: 99: 862-867.
28. Thompson CJ, Cummings F, Chalmers J, Newton RW. Abnormal insulin treatment behaviour: A major cause of ketoacidosis in the young adult. Diabet Med 1995: 12: 429-432.
29. Umpierrez GE, Kelly JP, Navarrete JE, Casals MM, Kitabchi AE. Hyperglycemic crises in urban blacks. Arch Intern Med 1997: 157: 669-675.
30. Rewers A, Chase HP, Mackenzie T, Walravens P, Roback M, Rewers M. Predictors of acute complications in children with type 1 diabetes. JAMA 2002: 287: 2511-2518.
31. Thomsett M, Shield G, Batch J, Cotterill A. How well are we doing? Metabolic control in patients with diabetes. J Paediatr Child Health 1999: 35: 479-482.
32. Steindel BS, Roe TR, Costin G, Carlson M, Kaufman FR. Continuous subcutaneous insulin infusion (CSII) in children and adolescents with chronic poorly controlled type 1 diabetes mellitus. Diabetes Res Clin Pract 1995: 27: 199-204.
33. Blackett PR. Insulin pump treatment for recurrent ketoacidosis in adolescence [letter]. Diabetes Care 1995: 18: 881-882.
34. Laffel LM, Wentzell K, Loughlin C, Tovar A, Moltz K, Brink S. Sick day management using blood 3-hydroxybutyrate (3-OHB) compared with urine ketone monitoring reduces hospital visits in young people with T1DM: A randomized clinical trial. Diabet Med 2006: 23: 278-284.
35. Hanas R, Lundqvist K, Windell L. Blood glucose and beta-hydroxybutyrate responses when the insulin pump is stopped in children and adolescents. Pediatr Diabetes 2006: 7 (Suppl. 5): 35 (abstract).
36. Linares MY, Schunk JE, Lindsay R. Laboratory presentation in diabetic ketoacidosis and duration of therapy. Pediatr Emerg Care 1996: 12: 347-351.
37. Bui TP, Werther GA, Cameron FJ. Trends in diabetic ketoacidosis in childhood and adolescence: A 15-yr experience. Pediatr Diabetes 2002: 3: 82-88.
38. Glasgow AM, Weissberg-Benchell J, Tynan WD, Epstein SF, Driscoll C, Turek J. Readmissions of children with diabetes mellitus to a children's hospital. Pediatrics 1991: 88: 98-104.
39. Edge JA, Hawkins MM, Winter DL, Dunger DB. The risk and outcome of cerebral oedema developing during diabetic ketoacidosis. Arch Dis Child 2001: 85: 16-22.
40. Golden MP, Herrold AJ, Orr DP. An approach to prevention of recurrent diabetic ketoacidosis in the pediatric population. J Pediatr 1985: 107: 195-200.
41. Kaufman FR, Halvorson M. The treatment and prevention of diabetic ketoacidosis in children and adolescents with type I diabetes mellitus. Pediatr Ann 1999: 28: 576-582.